Raphael Kübler

Raphael Kübler

Auto-generated profile, based on publicly available information

Raphael Kübler

Department of Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai, New York, NY, USA

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
6 January 2022 in Nature Genetics
Verified
Journal Article
Closed access
PDF file
KLKatia Lopes
Katia Lopes
GSGijsje J. L. Snijders
Gijsje J. L. Snijders
JHJack Humphrey
Jack Humphrey
AAAmanda Allan
Amanda Allan
MSMarjolein A. M. Sneeboer
Marjolein A. M. Sneeboer
TRTowfique Raj
Towfique Raj

4 May 2023 in Brain, Behavior, and Immunity
Verified
Journal Article
Closed access
RKRaphael Kübler
Raphael Kübler
POPaul R. Ormel
Paul R. Ormel
ISIris E.C. Sommer
Iris E.C. Sommer
RKRené S. Kahn
René S. Kahn
LWLot D. de Witte
Lot D. de Witte

26 May 2024 in bioRxiv
Verified
Preprint
Open access
PDF file
BABuonfiglioli Alice
Buonfiglioli Alice
RKRaphael Kübler
Raphael Kübler
RMRoy Missall
Roy Missall
RJRenske De Jong
Renske De Jong
SCStephanie Chan
Stephanie Chan
LWLot D. De Witte
Lot D. De Witte
Prenatal infections and activation of the maternal immune system have been proposed to contribute to causing neurodevelopmental disorders (NDDs), chronic conditions often linked to brain abnormalities. Microglia are the resident immune cells of the brain and play a key role in neurodevelopment. Disruption of microglial functions can lead to brain abnormalities and increase the risk of developing NDDs. How the maternal as well as the fetal immune system affect human neurodevelopment and contribute to NDDs remains unclear. An important reason for this knowledge gap is the fact that the impact of exposure to prenatal risk factors has been challenging to study in the human context. Here, we characterized a model of cerebral organoids (CO) with integrated microglia (COiMg). These organoids express typical microglial markers and respond to inflammatory stimuli. The presence of microglia influences cerebral organoid development, including cell density and neural differentiation, and regulates the expression of several ciliated mesenchymal cell markers. Moreover, COiMg and organoids without microglia show similar but also distinct responses to inflammatory stimuli. Additionally, IFN-γ induced significant transcriptional and structural changes in the cerebral organoids, that appear to be regulated by the presence of microglia. Specifically, interferon-gamma (IFN-γ) was found to alter the expression of genes linked to autism. This model provides a valuable tool to study how inflammatory perturbations and microglial presence affect neurodevelopmental processes.

28 October 2026 in medRxiv
Verified
Preprint
Open access
PDF file
RKRaphael Kübler
Raphael Kübler
DMDaniele Mattei
Daniele Mattei
JNJ. Oriol Narcis
J. Oriol Narcis
CSClaudia De Sanctis
Claudia De Sanctis
KHKosei Hirata
Kosei Hirata
TRTowfique Raj
Towfique Raj
Parkinson’s disease (PD) and related α-synucleinopathies are defined by the spread of Lewy body (LB) pathology across vulnerable brain regions, yet how substantia nigra (SN) myeloid cells respond remains unresolved. Using SOX10-based oligodendrocyte depletion and CD11b-based myeloid enrichment, we profiled 169,799 brain myeloid cells and nuclei from 96 donors spanning the LB continuum, including 86,427 from the SN, and integrated them with AMP PD for a total of 298,592 profiles. Across eight conserved states, α-synucleinopathy is associated with a bidirectional signature: upregulated glycolytic and proteostatic-stress programs alongside downregulated lysosomal and mitochondrial pathways. Microglia shift from P2RY12-high sensome cells toward an HSP90AA1-high proteostatic stress state, a transition that intensifies at late Braak LB stages. Immunohistochemistry confirmed that HSP60 + proteostatic microglia state proportions increase with SN neuron loss. A rare NUCKS1-high state (∼1% of myeloid cells), more abundant in late-stage disease, carried the strongest PD polygenic-risk loading. The PD-protective rs3732765-A allele, a microglial cis-eQTL that lowers P2RY12 expression, was nominally associated with a higher proportion of P2RY12-high microglia and higher lysosomal program activity. These findings frame microglial involvement as structured and genetically tractable, nominating the P2RY12 genetic axis and NUCKS1-high microglia for mechanistic studies.